Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2018 Filed Jun 19, 2018 17:47 UTC |
JULIBER LOIS DDirector
|
GrantCommon Stock | 566.663 | $67.75 | $38,391.42 |
DisclosureSEC source: 0001127294-18-000005 · edgar.xml · nonDerivative · entry 1 JULIBER LOIS D · CIK 0001127294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,151.8361 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:54 UTC |
BREEN EDWARD DDirector · Chief Executive Officer
|
GrantDeferred Stock Units · Derivative | 4.1732 | $67.75 | $282.73 |
DisclosureSEC source: 0001666700-18-000031 · edgar.xml · derivative · entry 3 BREEN EDWARD D · CIK 0001223619 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748.2821 Underlying: Common Stock · 4.1732 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents the right to receive one share of DowDuPont common stock. F3 · derivative.exercise_date: Units are payable in shares following termination of the reporting person's employment with DowDuPont. The reporting person may transfer his units into an alternative investment account at any time. F3 · derivative.expiration_date: Units are payable in shares following termination of the reporting person's employment with DowDuPont. The reporting person may transfer his units into an alternative investment account at any time. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:54 UTC |
BREEN EDWARD DDirector · Chief Executive Officer
|
GrantCommon Stock | 1,525.8979 | $67.75 | $103,379.58 |
DisclosureSEC source: 0001666700-18-000031 · edgar.xml · nonDerivative · entry 1 BREEN EDWARD D · CIK 0001223619 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,652.4782 F1 · balance_after: Includes unvested RSUs, deferred stock units and direct ownership Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:53 UTC |
Desmond Jeanmarie F.Co-Controller
|
GrantCommon Stock | 48.6252 | $67.75 | $3,294.36 |
DisclosureSEC source: 0001713192-18-000005 · edgar.xml · nonDerivative · entry 1 Desmond Jeanmarie F. · CIK 0001713192 · Co-Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,294.2908 F1 · balance_after: Includes direct ownership and unvested RSUs Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:52 UTC |
FOX STACY LGeneral Counsel & Secretary
|
GrantCommon Stock | 462.0406 | $67.75 | $31,303.25 |
DisclosureSEC source: 0001280220-18-000005 · edgar.xml · nonDerivative · entry 1 FOX STACY L · CIK 0001280220 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,563.2752 F1 · balance_after: Includes direct ownership and unvested restricted stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:50 UTC |
Collins James C. Jr.Chief Operating Officer
|
GrantDeferred Stock Units · Derivative | 0.0135 | $67.75 | $0.91 |
DisclosureSEC source: 0001625045-18-000005 · edgar.xml · derivative · entry 2 Collins James C. Jr. · CIK 0001625045 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2.4841 Underlying: Common Stock · 0.0135 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents the right to receive one share of DowDuPont common stock. F3 · derivative.exercise_date: Units are payable in shares following termination of the reporting person's employment with DowDuPont. F3 · derivative.expiration_date: Units are payable in shares following termination of the reporting person's employment with DowDuPont. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:50 UTC |
Collins James C. Jr.Chief Operating Officer
|
GrantCommon Stock | 699.1756 | $67.75 | $47,369.15 |
DisclosureSEC source: 0001625045-18-000005 · edgar.xml · nonDerivative · entry 1 Collins James C. Jr. · CIK 0001625045 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,853.5112 F1 · balance_after: Includes direct ownership and unvested restricted stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:51 UTC |
Doyle Christopher MarcChief Operating Officer
|
GrantCommon Stock | 644.6857 | $67.75 | $43,677.46 |
DisclosureSEC source: 0001660483-18-000005 · edgar.xml · nonDerivative · entry 1 Doyle Christopher Marc · CIK 0001660483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,013.2199 F1 · balance_after: Includes direct ownership and unvested restricted stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:45 UTC |
CUTLER ALEXANDER MDirector
|
GrantCommon Stock | 459.4482 | $67.75 | $31,127.62 |
DisclosureSEC source: 0001188585-18-000005 · edgar.xml · nonDerivative · entry 1 CUTLER ALEXANDER M · CIK 0001188585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,505.6886 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:46 UTC |
HEWSON MARILLYN ADirector
|
GrantRestricted DowDuPont Common Stock Units · Derivative | 26.1027 | $67.75 | $1,768.46 |
DisclosureSEC source: 0001217496-18-000003 · edgar.xml · derivative · entry 2 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,679.9433 Underlying: Common Stock · 26.1027 shares Expires not disclosed F2 · derivative.exercise_price: Units convert one-for-one to DowDuPont common stock. F3 · kind: Dividend equivalents credited as stock units under the DowDuPont Stock Accumulation and Deferred Compensation Plan for Directors. F5 · price: Price used to calculate dividend equivalents. F4 · derivative.exercise_date: Common stock units to be paid in cash upon reporting person's retirement. F4 · derivative.expiration_date: Common stock units to be paid in cash upon reporting person's retirement. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:46 UTC |
HEWSON MARILLYN ADirector
|
GrantCommon Stock | 325.8507 | $67.75 | $22,076.38 |
DisclosureSEC source: 0001217496-18-000003 · edgar.xml · nonDerivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,133.6604 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:49 UTC |
Ward PatDirector
|
GrantCommon Stock | 88.8876 | $67.75 | $6,022.13 |
DisclosureSEC source: 0001666700-18-000030 · edgar.xml · nonDerivative · entry 1 Ward Pat · CIK 0001436125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,941.6038 F1 · balance_after: Includes unvested restricted stock units and direct ownership. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:45 UTC |
BROWN ROBERT ADirector
|
GrantRestricted DowDuPont Common Stock Units · Derivative | 23.9602 | $67.75 | $1,623.30 |
DisclosureSEC source: 0001398379-18-000003 · edgar.xml · derivative · entry 3 BROWN ROBERT A · CIK 0001398379 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,295.8386 Underlying: Common Stock · 23.9602 shares Expires not disclosed F2 · derivative.exercise_price: Units convert one-for-one to DowDuPont Common Stock. F3 · kind: Dividend equivalents credited as restricted stock units under the DowDuPont Stock Accumulation and Deferred Compensation Plan for Directors. F5 · price: Price used to calculate dividend equivalents. F4 · derivative.exercise_date: Stock units to be paid in cash in five equal annual installments beginning the first year after reporting person's retirement. F4 · derivative.expiration_date: Stock units to be paid in cash in five equal annual installments beginning the first year after reporting person's retirement. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:45 UTC |
BROWN ROBERT ADirector
|
GrantCommon Stock | 254.5438 | $67.75 | $17,245.34 |
DisclosureSEC source: 0001398379-18-000003 · edgar.xml · nonDerivative · entry 1 BROWN ROBERT A · CIK 0001398379 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,637.0921 F1 · balance_after: Includes unvested RSUs Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 21:44 UTC |
ANDREOTTI LAMBERTODirector
|
GrantCommon Stock | 120.1198 | $67.75 | $8,138.12 |
DisclosureSEC source: 0001666700-18-000028 · edgar.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,536.2116 F1 · balance_after: Represents unvested RSUs Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 26,098 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · derivative · entry 9 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,694 Underlying: Common Stock · 26,098 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 26,098 | $69.58 | $1,815,898.84 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.65. Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 26,098 | $9.53 | $248,713.94 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,716.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 73,902 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · derivative · entry 8 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,792 Underlying: Common Stock · 73,902 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 73,902 | $69.57 | $5,141,066.53 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $69.55 to $69.60. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 21:38 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 73,902 | $9.53 | $704,286.06 |
DisclosureSEC source: 0001225208-18-010626 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,520.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 68,406 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · derivative · entry 12 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,694 Underlying: Common Stock · 68,406 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F6 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 68,406 | $69.50 | $4,754,217.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · price: All trades occurred at a price of $69.50. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 68,406 | $9.53 | $651,909.18 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 5 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,024.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · derivative · entry 11 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,100 Underlying: Common Stock · 100,000 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F6 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · derivative · entry 10 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,100 Underlying: Common Stock · 100,000 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F6 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 100,000 | $68.21 | $6,820,700.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 4 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $68.20 to 68.24. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 100,000 | $69.28 | $6,927,700.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 3 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $69.25 to $69.49. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 100,000 | $9.53 | $953,000.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,618.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 22:02 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 100,000 | $9.53 | $953,000.00 |
DisclosureSEC source: 0001225208-18-010428 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,618.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 9,610 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · derivative · entry 8 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,645 Underlying: Common Stock · 9,610 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 10,231 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · derivative · entry 7 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,231 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F2 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 10,231 | $68.40 | $699,800.40 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 9,610 | $68.40 | $657,324.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,079.7416 Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionCommon Stock | 9,610 | $32.16 | $309,057.60 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,689.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionCommon Stock | 10,231 | $34.00 | $347,854.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,079.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 16:39 UTC |
JULIBER LOIS DDirector
|
GrantCommon Stock | 272.9683 | $64.11 | $17,500.00 |
DisclosureSEC source: 0001127294-18-000004 · edgar.xml · nonDerivative · entry 1 JULIBER LOIS D · CIK 0001127294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,585.1731 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:34 UTC |
CUTLER ALEXANDER MDirector
|
GrantCommon Stock | 721.4163 | $64.11 | $46,250.00 |
DisclosureSEC source: 0001188585-18-000004 · edgar.xml · nonDerivative · entry 1 CUTLER ALEXANDER M · CIK 0001188585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,046.2404 F1 · balance_after: Includes direct ownership, unvested RSUs and vested deferred stock units. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 91,035 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · derivative · entry 8 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,255 Underlying: Common Stock · 91,035 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F6 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 38,813 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · derivative · entry 7 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,231 Underlying: Common Stock · 38,813 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 91,035 | $68.41 | $6,227,613.32 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.72. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
SaleCommon Stock | 38,813 | $68.43 | $2,656,012.40 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,883.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.66. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionCommon Stock | 38,813 | $34.00 | $1,319,642.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,696.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC |
KALIL CHARLES JSpecial Counsellor · General Counsel-MatCo
|
Exercise / conversionCommon Stock | 91,035 | $32.16 | $2,927,685.60 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,883.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:59 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001225208-18-009783 · doc4.xml · derivative · entry 6 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,100 Underlying: Common Stock · 100,000 shares Expires 2019-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 13, 2010. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:59 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
SaleCommon Stock | 100,000 | $68.50 | $6,850,000.00 |
DisclosureSEC source: 0001225208-18-009783 · doc4.xml · nonDerivative · entry 2 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,618.089 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: All sales occurred at a price of $68.50. Read SEC document |
| May 21, 2018 Filed May 23, 2018 20:59 UTC |
LIVERIS ANDREW NFormer Executive Chairman
|
Exercise / conversionCommon Stock | 100,000 | $9.53 | $953,000.00 |
DisclosureSEC source: 0001225208-18-009783 · doc4.xml · nonDerivative · entry 1 LIVERIS ANDREW N · CIK 0001269971 · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,618.089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 22, 2018 20:32 UTC |
Fitterling James RChief Operating Officer-MatCo
|
GiftCommon Stock | 8,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009734 · doc4.xml · nonDerivative · entry 1 Fitterling James R · CIK 0001490029 · Chief Operating Officer-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,842.949 Read SEC document |
| May 15, 2018 Filed Feb 8, 2019 22:16 UTC |
BREEN EDWARD DDirector · Chief Executive Officer
|
GiftCommon Stock | 3,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000030554-19-000002 · edgar.xml · nonDerivative · entry 1 BREEN EDWARD D · CIK 0001223619 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Family trust (GRAT) Disclosed balance after: 260,761.9527 F1 · balance_after: Includes direct ownership and unvested restricted stock units. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 17:18 UTC |
RINGLER JAMES MDirector
|
GrantCommon Stock | 2,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-008098 · doc4.xml · nonDerivative · entry 1 RINGLER JAMES M · CIK 0001009139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,311 F1 · shares: Award of stock with transfer restrictions exempt under Rule 16b-3 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.